Literature DB >> 15063118

Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy.

Peter Dickie1, Amanda Roberts, Richard Uwiera, Jennifer Witmer, Kirti Sharma, Jeffrey B Kopp.   

Abstract

Clinical and morphologic features of human immunodeficiency virus (HIV)-associated nephropathy (HIVAN), such as proteinuria, sclerosing glomerulopathy, tubular degeneration, and interstitial disease, have been modeled in mice bearing an HIV proviral transgene rendered noninfectious through a deletion in gag/pol. Exploring the genetic basis of HIVAN, HIV transgenic mice bearing mutations in either or both of the accessory genes nef and vpr were created. Proteinuria and focal glomerulosclerosis (FGS) only developed in mice with an intact vpr gene. Transgenic mice bearing a simplified proviral DNA (encoding only Tat and Vpr) developed renal disease characterized by FGS in which Vpr protein was localized to glomerular and tubular epithelia by immunohistochemistry. The dual transgenic progeny of HIV[Tat/Vpr] mice bred to HIV[DeltaVpr] proviral transgenic mice displayed a more severe nephropathy with no apparent increase in Vpr expression, implying that multiple viral genes contribute to HIVAN. However, the unique contribution of macrophage-specific Vpr expression in the development of glomerular disease was underscored by the induction of FGS in multiple murine lines bearing a c-fms/vpr transgene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063118     DOI: 10.1016/j.virol.2004.01.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

Review 1.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

2.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 3.  Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.

Authors:  Marina Núñez; Anita M Saran; Barry I Freedman
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

4.  Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy.

Authors:  Scott Martinka; Leslie A Bruggeman
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-04

Review 5.  HIV-associated renal disorders: recent insights into pathogenesis and treatment.

Authors:  Ruth Berggren; Vecihi Batuman
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

Review 6.  HIV and the kidney: a status report after 20 years.

Authors:  Monique E Cho; Jeffrey B Kopp
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

Review 7.  Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Authors:  Christopher Power; Elizabeth Hui; Pornpun Vivithanaporn; Shaona Acharjee; Maria Polyak
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-15       Impact factor: 4.147

Review 8.  Controversies in the pathogenesis of HIV-associated renal diseases.

Authors:  Leslie A Bruggeman; Peter J Nelson
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

Review 9.  Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.

Authors:  Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

10.  HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells.

Authors:  Paul E Rosenstiel; Tina Gruosso; Audrey M Letourneau; Justin J Chan; Amanda LeBlanc; Mohammad Husain; Vesna Najfeld; Vicente Planelles; Vivette D D'Agati; Mary E Klotman; Paul E Klotman
Journal:  Kidney Int       Date:  2008-07-09       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.